The Institute serves as a catalyst for global collaboration,
working with partners across the University of North Carolina and around the world.
Leading the response to COVID-19
At the onset of the pandemic, Institute for Global Health and Infectious Diseases researchers sprang into action, advising and partnering with the NIH, WHO and others on a coordinated response. By August 2020, Institute clinicians and researchers were engaged in 52 research projects including national vaccine and treatment trials. Watch the video at left to learn more.
Cindy Gay, MD, on leading COVID-19 vaccine trial; Ron Falk, MD, on participating
Michelle Floris-Moore, MD, MS, talks about impact of COVID-19 on African Americans
Michael Herce, MD, MPH, MSc: ¿Por qué participar en un esayo clinico?
Big Tent, One Team:
How a multidisciplinary research partnership built to fight HIV, Ebola, and other infectious diseases turned its people, expertise, and experience to fight COVID-19
In his March 23, 2021 story in UNC’s The Well, writer Scott Jared takes a deep look at the history and accomplishments of the Institute and Division of Infectious Diseases, especially how Institute Director Myron Cohen and ID Chief Joe Eron have cultivated a Big Tent way of thinking in which professionals of varying expertise work in synch with each other. The Big Tent philosophy “has no silos,” Cohen says. “We’re all working together on problems, and we all work together very successfully.”
Read story
2018-2020 Impact Report:
Pandemic highlights Institute’s critical role
Our abbreviated report includes updates from the Institute’s global sites, stats on the breadth and impact of our work, and a look at the COVID-19 research that our faculty launched in the spring of 2020 in reaction to the pandemic.
Download impact report
Now More Than Ever, Global is Local
Latest Institute news
-
Bamlanivimab reduces risk of COVID in skilled nursing homes and assisted living facilities, study finds
UNC’s Institute of Global Health and Infectious Diseases Director Myron Cohen, MD, is the lead investigator of a study recently published in the Journal of the American Medical Association (JAMA) that shows bamlanivimab monotherapy reduced the incidence of infection in skilled nursing homes and assisted living facilities with high risk of SARS-CoV-2 exposure. The randomized phase 3 clinical trial … Continued
-
Study compares mortality of people entering HIV care with general US population
HIV-related mortality has decreased since 1996 due to improved treatments and evolving care guidelines, but the extent to which persons entering HIV care have a higher risk for death over the following years, compared with peers in the general population, has been unclear. Joseph Eron, MD, the Herman and Louise Smith Distinguished Professor of Medicine … Continued
-
Five UNC resident physicians and fellows named Global Health Scholars
The Office of Global Health Education has selected its 2021-2023 cohort of Global Health Scholars. The competitive two-year program supports the career and leadership development of UNC fellows and resident physicians who have a strong interest in global health. The scholars’ selection includes $8,000 to support research proposals. Supporting the scholars as second advisors … Continued